RARE Financials
Ultragenyx - Financial statements & key metrics
Stock Price
$25.13
Market Cap
$2.79B
P/E Ratio
-4.0
EPS
$-5.93
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$560.23M
Gross Profit
-
Operating Income
-
Net Income
$-569.18M
EPS (Diluted)
$-6.29
Balance Sheet Highlights
Total Assets
$1.50B
Total Liabilities
$1.24B
Shareholders Equity
-
Cash & Equivalents
$173.73M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-414.19M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-106.8%
Net Margin
-92.0%
ROE
-313.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RARE revenue?
RARE's most recent quarterly revenue was $560.23M. Annual revenue can be calculated by summing the four most recent quarters.
Is RARE profitable?
RARE reported a loss of $569.18M in the most recent quarter. The net profit margin is -92.0%.
What is RARE market cap?
RARE has a market capitalization of $2.79B, making it a mid-cap stock.
Does RARE have debt?
View RARE's balance sheet for debt information.
What is RARE cash flow?
Cash flow data is available in the full financial statements.